|
1
|
No authors listed. A clinical evaluation
of the International Lymphoma Study Group classification of
non-Hodgkin’s lymphoma. The Non-Hodgkin’s Lymphoma Classification
Project. Blood. 89:3909–3918. 1997.
|
|
2
|
Nishiu M, Yanagawa R, Nakatsuka S, et al:
Microarray analysis of gene-expression profiles in diffuse large
B-cell lymphoma: identification of genes related to disease
progression. Jpn J Cancer Res. 93:894–901. 2002.
|
|
3
|
Bavi P, Uddin S, Bu R, et al: The
biological and clinical impact of inhibition of NF-κB-initiated
apoptosis in diffuse large B cell lymphoma (DLBCL). J Pathol.
224:355–366. 2011.
|
|
4
|
Malumbres R, Sarosiek KA, Cubedo E, et al:
Differentiation stage-specific expression of microRNAs in B
lymphocytes and diffuse large B-cell lymphomas. Blood.
113:3754–3764. 2009.
|
|
5
|
Alencar AJ, Malumbres R, Kozloski GA, et
al: MicroRNAs are independent predictors of outcome in diffuse
large B-cell lymphoma patients treated with R-CHOP. Clin Cancer
Res. 17:4125–4135. 2011.
|
|
6
|
Li C, Thompson MA, Tamayo AT, et al:
Over-expression of Thioredoxin-1 mediates growth, survival, and
chemoresistance and is a druggable target in diffuse large B-cell
lymphoma. Oncotarget. 3:314–326. 2012.
|
|
7
|
Zhong H, Xu L, Zhong JH, et al: Clinical
and prognostic significance of miR-155 and miR-146a expression
levels in formalin-fixed/paraffin-embedded tissue of patients with
diffuse large B-cell lymphoma. Exp Ther Med. 3:763–770. 2012.
|
|
8
|
Ruminy P, Etancelin P, Couronné L, et al:
The isotype of the BCR as a surrogate for the GCB and ABC molecular
subtypes in diffuse large B-cell lymphoma. Leukemia. 25:681–688.
2011.
|
|
9
|
Matsuyama H, Suzuki HI, Nishimori H, et
al: miR-135b mediates NPM-ALK-driven oncogenicity and renders
IL-17-producing immunophenotype to anaplastic large cell lymphoma.
Blood. 118:6881–6892. 2011.
|
|
10
|
Hobert O: Gene regulation by transcription
factors and microRNAs. Science. 319:1785–1786. 2008.
|
|
11
|
Latchman DS: Transcription factors: an
overview. Int J Biochem Cell Biol. 29:1305–1312. 1997.
|
|
12
|
Chen K and Rajewsky N: The evolution of
gene regulation by transcription factors and microRNAs. Nat Rev
Genet. 8:93–103. 2007.
|
|
13
|
Betel D, Wilson M, Gabow A, et al: The
microRNA.org resource: targets and expression. Nucleic Acids Res.
36:D149–D153. 2008.
|
|
14
|
Papadopoulos GL, Reczko M, Simossis VA, et
al: The database of experimentally supported targets: a functional
update of TarBase. Nucleic Acids Res. 37:D155–D158. 2009.
|
|
15
|
Hsu SD, Lin FM, Wu WY, et al: miRTarBase:
a database curates experimentally validated microRNA-target
interactions. Nucleic Acids Res. 39:D163–D169. 2011.
|
|
16
|
Rodriguez A, Griffiths-Jones S, Ashurst JL
and Bradley A: Identification of mammalian microRNA host genes and
transcription units. Genome Res. 14:1902–1910. 2004.
|
|
17
|
Baskerville S and Bartel DP: Microarray
profiling of microRNAs reveals frequent coexpression with
neighboring miRNAs and host genes. RNA. 11:241–247. 2005.
|
|
18
|
Cao G, Huang B, Liu Z, et al: Intronic
miR-301 feedback regulates its host gene, ska2, in A549 cells by
targeting MEOX2 to affect ERK/CREB pathways. Biochem Biophys Res
Comm. 396:978–982. 2010.
|
|
19
|
Wang J, Lu M, Qiu C and Cui Q: TransmiR: a
transcription factor-microRNA regulation database. Nucleic Acids
Res. 38:D119–D122. 2010.
|
|
20
|
Kozomara A and Griffiths-Jones S: miRBase
integrating microRNA annotation and deep-sequencing data. Nucleic
Acids Res. 39:D152–D157. 2011.
|
|
21
|
Safran M, Dalah I, Alexander J, et al:
GeneCards Version 3: the human gene integrator. Database (Oxford).
baq0202010.
|
|
22
|
Chekmenev DS, Haid C and Kel AE: P-Match:
transcription factor binding site search by combining patterns and
weight matrices. Nucleic Acids Res. 33:W432–W437. 2005.
|
|
23
|
Fujita PA, Rhead B, Zweig AS, et al: The
UCSC Genome Browser database: update 2011. Nucleic Acids Res.
39:D876–D882. 2011.
|
|
24
|
Jiang Q, Wang Y, Hao Y, et al:
miR2Disease: a manually curated database for microRNA deregulation
in human disease. Nucleic Acids Res. 37:D98–D104. 2009.
|
|
25
|
Huang X, Shen Y, Liu M, et al:
Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT
pathway in diffuse large B-Cell lymphoma. Am J Pathol. 181:26–33.
2012.
|
|
26
|
Diniz MG, Gomes CC, de Castro WH, et al:
miR-15a/16–1 influences BCL2 expression in keratocystic odontogenic
tumors. Cellular Oncol. 35:285–291. 2012.
|
|
27
|
Chen RW, Bemis LT, Amato CM, et al:
Truncation in CCND1 mRNA alters miR-16–1 regulation in mantle cell
lymphoma. Blood. 112:822–829. 2008.
|
|
28
|
Poliseno L, Salmena L, Riccardi L, et al:
Identification of the miR-106b~25 microRNA cluster as a
proto-oncogenic PTEN-targeting intron that cooperates with its host
gene MCM7 in transformation. Sci Signal. 3:ra292010.
|
|
29
|
Kumar M, Lu Z, Takwi AA, et al: Negative
regulation of the tumor suppressor p53 gene by microRNAs. Oncogene.
30:843–853. 2011.
|
|
30
|
Ahn YH, Gibbons DL, Chakravarti D, et al:
ZEB1 drives prometastatic actin cytoskeletal remodeling by
downregulating miR-34a expression. J Clin Invest. 122:3170–3183.
2012.
|
|
31
|
Bhat-Nakshatri P, Wang G, Collins NR, et
al: Estradiol-regulated microRNAs control estradiol response in
breast cancer cells. Nucleic Acids Res. 37:4850–4861. 2009.
|
